John P. Butler Akebia Therapeutics, Inc. (AKBA) insider trading activity
John P. Butler is CEO and President of Akebia Therapeutics, Inc.. Currently has a direct ownership of 2.04 Million shares of AKBA, which is worth approximately $3.74 Million. The most recent transaction as insider was on Feb 29, 2024, when has been sold 46,570 shares (Common Stock) at a price of $1.58 per share, resulting in proceeds of $73,580. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.04M
0%
3M change
30.32%
12M change
Total Value Held
$3.74 Million
John P. Butler Transaction History
Also insider at
JPB
John P. Butler
CEO and President
Cambridge, MA